News
Clinical trial tech outfit Medidata has elevated a new strategy leader from within. | Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa ...
5h
TipRanks on MSNAmgen’s Pediatric SHPT Study: A Potential Game-Changer for Etelcalcetide
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 study titled Phase 3, ...
President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.
Amgen Inc. has witnessed a notable reduction in stock holdings by Donoghue Forlines LLC, slicing 17.6% to stand at 4,656 ...
The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.
Since 2018, Brown University has hosted dozens of interns through PrepareRI, a statewide initiative that helps high schoolers ...
Amgen Inc. reported a robust quarterly performance, surpassing analyst expectations with a notable revenue increase of 9.4%. ...
Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint.
We read with interest the Correspondence by Zhiqi Yao and colleagues1 published in The Lancet Diabetes & Endocrinology, which ...
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results